| Name | Title | Contact Details |
|---|
At MELA Sciences, we design and develop innovative software-driven medical technologies for physician clinical use during the detection of skin cancers at the most curable and cost-effective stages. Our mission is to develop breakthrough medical technologies to improve skin cancer detection and achieve better outcomes for all. We envision a world in which our pioneering innovations will change the way patients think about skin cancer, while providing dermatologists and clinicians with new, effective, non-invasive tools for the earliest detection possible. MELA Sciences conducted the largest, positive prospective study ever done on the melanoma disease, and is the first and only medical technology company to receive both FDA Pre-Market Approval (PMA) for the U.S. and CE Marking certification for the European Union for a device of this nature. The company’s flagship product, MelaFind®, is intended to provide dermatologists with software-driven image analysis of clinically atypical pigmented skin lesions when they choose to obtain additional information to help decide whether to biopsy or not. The FDA has approved MELA Sciences’ MelaFind® Pre-Market Approval application for use in the United States and MELA Sciences has also been granted CE Mark approval for sale of MelaFind® in the European Union.
Blue Stream Laboratories is a Cambridge, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
NutriSavings mission is to reduce the cost of healthcare by educating employees on healthy eating and rewarding good food choices with savings at the supermarket, grocery store, or farmers market. NutriSavings is a joint venture between Edenred (NYSE Euronext), the world leader in corporate services, and SavingStar, the only national fully digital grocery savings service in the US.
Cummins Behavioral Health Systems is a Avon, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Ziehm Imaging is a Orlando, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.